Carregant...
Selective Estrogen Receptor Modulators Differentially Regulate Alzheimer-Like Changes in Female 3xTg-AD Mice
Estrogen-based hormone therapy (HT) in postmenopausal women may reduce the risk of Alzheimer’s disease (AD), although HT remains controversial. One key concern with HT is the potential of adverse outcomes such as breast and uterine cancer. A promising strategy to maximize HT benefits and minimize HT...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Endocrine Society
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2329277/ https://ncbi.nlm.nih.gov/pubmed/18276750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2007-1346 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|